MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Greenphire, LLC
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution - mProve Health integrates ClinCard with its patient engagement app to boost retention, compliance and improve patients’ clinical trial experience - mProve.com / Greenphire.com
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution

 

NewswireToday - /newswire/ - Boston, MA, United States, 2017/09/06 - mProve Health integrates ClinCard with its patient engagement app to boost retention, compliance and improve patients’ clinical trial experience - mProve.com / Greenphire.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

DPharm: Disruptive Innovations to Advance Clinical Trials
mProve Health, a leading provider of mobile technologies for patient engagement and electronic clinical outcome assessments (eCOA), and Greenphire, the global leader in clinical payment automation, today announced a partnership to provide patients with real-time access to ClinCard payment details via mProve’s engagement app, mPal.

mPal is a robust, regulatory-compliant mobile solution for patients to receive study appointment and medication reminders, access their study visit schedule, documents, research site, and education materials, among other services such as the ability to request a lab courier pickup. Through this exclusive partnership, clinical trial participants who are receiving payments or reimbursements via the most widely accepted and adopted participant payment solution, ClinCard, can have real-time access to their balance and payment history directly through mPal.

“mPal has become a patient engagement solution of choice for 18 of the top 20 pharmaceutical companies making real-time trial payment information available in the app is a natural product extension,” said Jeff Lee, CEO, mProve Health. “Since ClinCard is the most widely used patient payment solution, Greenphire is an ideal partner for us. We value Greenphire’s long standing commitment to delivering a high-quality participant experience, and we look forward to seeing the positive impact our partnership will have on our customers.”

Adding ClinCard capabilities to the mPal app creates a single, mobile touchpoint for patients to access their study services, eliminating the need to use different systems. The combined solution will improve patients’ clinical trial experience and make it easier for them to fulfill study commitments.

“The integration with mProve strengthens our product offering, further supporting our commitment to simplifying clinical trial participation and reducing any financial barriers that might impact retention,” said Jim Murphy, CEO, Greenphire. “This integration illustrates Greenphire’s investment in supporting the mobile health experience and we’re excited to integrate with such an innovative partner.”

The barriers to patient recruitment, retention and protocol adherence can have a significant impact on clinical research. According to CenterWatch, the average dropout rate across all clinical trials is around 30 percent; highlighting the importance of technologies that make participation easier.

Gretchen Goller, Global Head of Patient Recruitment at ICON plc, has first-hand experience using both solutions in pivotal clinical trials. Commenting on the integration, she said: “Both mProve Health’s mobile engagement solution and Greenphire’s ClinCard have proven to be valuable assets for ICON’s clients. Combining these two solutions into one patient touchpoint aligns perfectly with our model for delivering patient-centric services to our sponsors.”

mProve Health and Greenphire will be exhibiting at the 7th Annual DPharm: Disruptive Innovation to Advance Clinical Trials Conference, which is being held in Boston, MA, September 7-8, 2017, at booths #2 and #38, respectively. For more information, contact mProve Health or Greenphire to arrange a demo.

About Greenphire
Greenphire (greenphire.com) is the leader in global clinical trial payment solutions. Greenphire’s best-in-class solutions optimize clinical trial performance by simplifying and streamlining payment processes from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials.

About mProve Health
mProve Health (mprove.com) is a leading provider of mobile technologies for life science companies, helping them connect better with patients. The company offers industry-grade, regulatory compliant mobile solutions for patient recruitment, patient engagement, and electronic clinical outcome assessments (eCOA). mProve’s applications are used by 18 of the top 20 pharmaceutical companies, 15,000 clinical research sites in over 60 countries, and they are translated in over 50 languages to support patients across the globe. The company was founded in 2010 by Jeff Lee, CEO, an entrepreneur and mobile engagement strategist who founded three prior successful ventures, and Denis Curtin, PhD, CSO, a pharmacologist and pharmaceutical industry veteran.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Greenphire, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Press Office - Greenphire.com 
215-609-4378 / 215-609-4640 corporate[.]greenphire.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Greenphire, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Greenphire, LLC / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ipsen Showcases Commitment to Patient-centric Advances in Oncology with Record Number of Abstracts to be Presented At ESMO 2020 Virtual Congress
Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease Announced
Ipsen to Present New Insights At ASBMR for Potential Treatment of Ultra-rare Disease Fibrodysplasia Ossificans Progressiva (FOP)
Ipsen to Present Results from MOVE, the First Global Phase III Trial in Fibrodysplasia Ossificans Progressiva (FOP) At ASBMR 2020 Annual Meeting
DSM Ignites New Strategic Initiative to Transform Global Animal Nutrition and Health
Jamjoom Pharmaceuticals Earns Acclaim from Frost & Sullivan for its Dominance in the KSA Pharma Market
DSM and Avril Complete Creation of Joint Venture to Develop Plant-based Protein
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-small Cell Lung Cancer
Stevanato Group, SCHOTT, and Gerresheimer Confirm the Readiness to Support Future Covid-19 Vaccine with Pharmaceutical Containers
Ipsen Receives FDA Fast Track Designation for Liposomal Irinotecan (ONIVYDE®) as A First-line Combination Treatment for Metastatic Pancreatic Cancer
Ipsen Demonstrates Continued Commitment to Rare Diseases with Eight Abstracts Accepted At ENDO 2020 Published in the Journal of the Endocrine Society
Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  RightITnow, Inc.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)